Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 11
Submit an article Journal homepage
194
Views
10
CrossRef citations to date
0
Altmetric
Review

Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide

Stanley Schwartz University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]
Pages 3009-3022 | Accepted 06 Aug 2008, Published online: 02 Oct 2008

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Stanley Schwartz & Mary Herman. (2015) Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies. Postgraduate Medicine 127:5, pages 480-493.
Read now
Stanley Schwartz. (2014) Evidence-Based Practice Use of Incretin-Based Therapy in the Natural History of Diabetes. Postgraduate Medicine 126:3, pages 66-84.
Read now
Stanley S Schwartz. (2010) Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin. Diabetes, Metabolic Syndrome and Obesity 3, pages 243-252.
Read now

Articles from other publishers (7)

Silvio E. Inzucchi & David R. Matthews. 2017. Textbook of Diabetes. Textbook of Diabetes 471 492 .
P.K. Prabhakar, Anil Kumar & Mukesh Doble. (2014) Combination therapy: A new strategy to manage diabetes and its complications. Phytomedicine 21:2, pages 123-130.
Crossref
Stanley Schwartz, Anthony N. Fabricatore & Andrea Diamond. 2013. Diabetes. Diabetes 438 458 .
Zin Z Htike, Kamlesh Khunti & Melanie Davies. (2012) Exenatide: role in management of Type 2 diabetes and associated cardiovascular risk factors. Clinical Practice 9:1, pages 23-38.
Crossref
Stanley S. Schwartz & Benjamin A. Kohl. (2010) Glycemic Control and Weight Reduction Without Causing Hypoglycemia: The Case for Continued Safe Aggressive Care of Patients With Type 2 Diabetes Mellitus and Avoidance of Therapeutic Inertia. Mayo Clinic Proceedings 85:12, pages S15-S26.
Crossref
Angelos Kyriacou & Abu Baker Ahmed. (2010) Exenatide Use in the Management of Type 2 Diabetes Mellitus. Pharmaceuticals 3:8, pages 2554-2567.
Crossref
. (2009) Current World Literature. Current Opinion in Lipidology 20:6, pages 512-519.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.